Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingbaixinda is a Beijing-based biotechnology company specializing in the custom synthesis of high-quality peptides and related biochemical reagents. The company provides a comprehensive suite of services including stable isotope labeling, peptide modification, cyclic peptide synthesis, and protein expression. Qingbaixinda supports pharmaceutical companies and academic institutions in drug discovery and life science research by delivering complex and high-purity peptide sequences. Their technical team focuses on overcoming challenges in long-chain peptide synthesis and large-scale production for R&D purposes. In addition to custom synthesis, the company offers catalog products such as amino acid derivatives and specialty chemicals for the biotech industry. By maintaining rigorous quality control standards, Qingbaixinda has established itself as a reliable partner for researchers requiring precise molecular tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingbaixinda.